Senior Physician of the Department of Melanoma and Sarcoma Medical Oncology at Peking University Cancer Hospital, Associate Professor and Doctoral Supervisor of Peking University. He holds a Doctorate in Oncology from Peking University and is a Senior Visiting Scholar at Moffitt Cancer Center in the United States. He is a recipient of the National High‑Level Young Talent Program and a Boya Young Scholar of Peking University.

He has long been engaged in the clinical diagnosis and treatment of melanoma, sarcoma and urologic tumors, with particular expertise in precision diagnosis, treatment and translational research of melanoma. As a key member, he has initiated and participated in multiple prospective clinical studies on melanoma that have changed clinical practice. In recent years, he has published 15 SCI papers as corresponding or first author (including co‑authors) in prestigious journals such as Ann Oncol (2017, 2022, 2024), JAMA Oncol, Clin Cancer Res, Int J Radiat Oncol and Eur J Cancer. He has been invited to deliver 3 oral presentations at the Annual Meeting of the American Society of Clinical Oncology (ASCO). His research findings have been adopted by 7 domestic and international melanoma guidelines including NCCN, ASCO and SITC guidelines from the United States. He has authored 9 editions of 3 melanoma diagnosis and treatment guidelines issued by the National Health Commission, Chinese Society of Clinical Oncology (CSCO) and Chinese Anti‑Cancer Association. He has presided over 10 national and provincial‑ministerial research projects.

He has received numerous honors including Beijing Outstanding Young Backbone Talent, Young Sprout Talent of Beijing Hospital Management Center, Peking University Clinical Scientist (continued support), the first‑session CSCO "35 under 35 Most Promising Young Oncologist", and "Excellent Specialty Training Supervisor" of Peking University Health Science Center